Satisfactory growth and earnings for Novozymes. Sales rose by 15% in the first nine months, while growth in DKK was 11%. Operating profit rose by 14% challenged by unfavorable exchange rate movements and rising raw material and energy prices. Productivity improvements contributed to the positive development. Net profit for the period rose by 21% including one-off items. Novozymes is maintaining its outlook for 2007 in DKK. Download the whole stock exchange announcement
Attachments
